These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9496946)

  • 1. Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis.
    McLaren CE; McLachlan GJ; Halliday JW; Webb SI; Leggett BA; Jazwinska EC; Crawford DH; Gordeuk VR; McLaren GD; Powell LW
    Gastroenterology; 1998 Mar; 114(3):543-9. PubMed ID: 9496946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.
    Thorstensen K; Kvitland MA; Irgens WØ; Hveem K; Asberg A
    Scand J Clin Lab Invest; 2010 Apr; 70(2):92-7. PubMed ID: 20073670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes.
    Adams PC
    Am J Hematol; 1994 Feb; 45(2):146-9. PubMed ID: 8141120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HFE genotype in patients with hemochromatosis and other liver diseases.
    Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
    Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen typing of siblings in hereditary hemochromatosis: a cost approach.
    Adams PC; Kertesz AE
    Hepatology; 1992 Feb; 15(2):263-8. PubMed ID: 1735529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors.
    Adams PC; Kertesz AE; McLaren CE; Barr R; Bamford A; Chakrabarti S
    Hepatology; 2000 May; 31(5):1160-4. PubMed ID: 10796893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
    Bassett ML; Halliday JW; Ferris RA; Powell LW
    Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.
    Gochee PA; Powell LW; Cullen DJ; Du Sart D; Rossi E; Olynyk JK
    Gastroenterology; 2002 Mar; 122(3):646-51. PubMed ID: 11874997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic efficacy of screening tests for hereditary hemochromatosis.
    Borwein S; Ghent CN; Valberg LS
    Can Med Assoc J; 1984 Oct; 131(8):895-901. PubMed ID: 6593112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percent transferrin saturation in segregating hemochromatosis.
    Borecki IB; Rao DC; Yaouanq J; Lalouel JM
    Am J Med Genet; 1990 Jul; 36(3):301-5. PubMed ID: 2363427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study.
    Olynyk JK; Hagan SE; Cullen DJ; Beilby J; Whittall DE
    Mayo Clin Proc; 2004 Mar; 79(3):309-13. PubMed ID: 15008603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hereditary hemochromatosis in 16031 primary care patients.
    Phatak PD; Sham RL; Raubertas RF; Dunnigan K; O'Leary MT; Braggins C; Cappuccio JD
    Ann Intern Med; 1998 Dec; 129(11):954-61. PubMed ID: 9867748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria.
    Adams PC; Chakrabarti S
    Gastroenterology; 1998 Feb; 114(2):319-23. PubMed ID: 9453492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and phenotypic expression of hemochromatosis in Canadians.
    Borwein ST; Ghent CN; Flanagan PR; Chamberlain MJ; Valberg LS
    Clin Invest Med; 1983; 6(3):171-9. PubMed ID: 6652983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri.
    McDonnell SM; Hover A; Gloe D; Ou CY; Cogswell ME; Grummer-Strawn L
    Am J Med; 1999 Jul; 107(1):30-7. PubMed ID: 10403350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index.
    Summers KM; Halliday JW; Powell LW
    Hepatology; 1990 Jul; 12(1):20-5. PubMed ID: 2373481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.